1. Home
  2. LRN vs GKOS Comparison

LRN vs GKOS Comparison

Compare LRN & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stride Inc.

LRN

Stride Inc.

HOLD

Current Price

$86.62

Market Cap

3.6B

Sector

Real Estate

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$118.16

Market Cap

6.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LRN
GKOS
Founded
2000
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
6.9B
IPO Year
2007
2015

Fundamental Metrics

Financial Performance
Metric
LRN
GKOS
Price
$86.62
$118.16
Analyst Decision
Buy
Strong Buy
Analyst Count
4
14
Target Price
$106.75
$133.07
AVG Volume (30 Days)
1.0M
705.7K
Earning Date
04-28-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
26.87
N/A
EPS
3.49
N/A
Revenue
$917,734,000.00
$507,442,000.00
Revenue This Year
$6.06
$23.29
Revenue Next Year
$5.10
$27.74
P/E Ratio
$24.61
N/A
Revenue Growth
3.29
32.33
52 Week Low
$60.61
$73.16
52 Week High
$171.17
$130.23

Technical Indicators

Market Signals
Indicator
LRN
GKOS
Relative Strength Index (RSI) 63.63 51.87
Support Level $62.76 $79.71
Resistance Level $91.60 $130.23
Average True Range (ATR) 3.13 5.31
MACD -0.35 0.44
Stochastic Oscillator 76.55 74.50

Price Performance

Historical Comparison
LRN
GKOS

About LRN Stride Inc.

Stride Inc is an American online educational company. It offers alternative programs to traditional on-campus schooling. It also operates state-funded virtual charter schools around the United States. The educational programs for K-12 students are usually monitored by parents and provide virtual classroom environments where teachers meet with students online, by phone, or in-person. The company's contractual agreements with various school districts to offer its curriculum programs provide a majority of the company's revenue. The company lines of business are Managed Public School Programs, Institutional and Private Pay Schools and Other.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: